Company: QTIWW
Filing Date: 2025-07-17
Form Type: DEF 14A
Source: 0001844505-25-000069
Chunk: 43

Company: QT IMAGING HOLDINGS, INC.
Filing Date: 2025-07-17
Form: DEF 14A
Chunk 43
---
 | 2024 |     |        |       — |     |               |       — |     |       |      — |     |              |      — |     |       |       — |
| Anastas Budagov(3)                                                   
 Chief Financial Officer                                              |     | 2023 |     |        |       — |     |               |       — |     |       |      — |     |              |      — |     |       |       — |
|                                                                      |     | 2024 |     |        | 290,846 |     |               | 153,725 |     |       | 63,333 |     |              |      — |     |       | 507,904 |
| Mikel Ann Price(4)                                                   
 Former Chief Financial Officer                                       |     | 2023 |     |        | 267,596 |     |               |       — |     |       |      — |     |              | 22,211 |     |       | 289,807 |
|                                                                      |     | 2024 |     |        |       — |     |               |       — |     |       |      — |     |              |      — |     |       |       — |

<div align='center'>24</div>

#### TABLE OF CONTENTS
__________________

(1) Consists of shares of common stock of the Company issuable upon vesting and exercise of stock options. The amounts in this column represent the aggregate grant date fair value computed in accordance with FASB ASC Topic 718.

(2) On March 12, 2024, the Board appointed Dr. Raluca Dinu to serve as the Chief Executive Officer of the Company, effective immediately. Dr. Raluca Dinu’s base salary per her employment agreement, which the Board approved on March 18, 2024, effective as of March 12, 2024 was $470,000. On July 3, 2024, the Board approved the grant of 550,000 stock options to Dr. Raluca Dinu. The stock options have an exercise price of $0.748 per option and a grant date fair value of $0.47 per option. One-third of the stock options granted will vest on February 15, 2025, and the remaining two-thirds of the stock options will vest quarterly over a two year period thereafter.

(3) On March 12, 2024, the Board ratified the